Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA grants approval to Merck & Co.'s Keytruda as first-line combination therapy in NSCLC

firstwordpharmaMay 11, 2017

Tag: Merck , NSCLC

PharmaSources Customer Service